Mary Kay Ladone Sells 3,125 Shares of Hill-Rom Holdings, Inc. (NYSE:HRC) Stock

Hill-Rom Holdings, Inc. (NYSE:HRC) SVP Mary Kay Ladone sold 3,125 shares of the firm’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $106.00, for a total transaction of $331,250.00. Following the completion of the transaction, the senior vice president now directly owns 13,566 shares in the company, valued at approximately $1,437,996. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

NYSE HRC opened at $108.21 on Wednesday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.22 and a current ratio of 1.52. The company has a market capitalization of $7.17 billion, a price-to-earnings ratio of 49.64, a price-to-earnings-growth ratio of 1.26 and a beta of 0.70. The company’s 50-day simple moving average is $100.58 and its two-hundred day simple moving average is $105.04. Hill-Rom Holdings, Inc. has a one year low of $72.29 and a one year high of $117.50.

Hill-Rom (NYSE:HRC) last released its quarterly earnings results on Friday, May 1st. The medical technology company reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.15 by $0.13. Hill-Rom had a net margin of 5.04% and a return on equity of 22.60%. The business had revenue of $723.20 million for the quarter, compared to analysts’ expectations of $701.72 million. During the same period last year, the business earned $1.14 EPS. The company’s revenue was up 1.3% compared to the same quarter last year. Equities analysts expect that Hill-Rom Holdings, Inc. will post 5.45 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Friday, June 19th were issued a $0.22 dividend. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date of this dividend was Thursday, June 18th. Hill-Rom’s dividend payout ratio is currently 17.32%.

Several large investors have recently added to or reduced their stakes in HRC. BDO Wealth Advisors LLC acquired a new stake in Hill-Rom in the 1st quarter worth approximately $29,000. Signaturefd LLC lifted its stake in Hill-Rom by 53.3% during the 1st quarter. Signaturefd LLC now owns 302 shares of the medical technology company’s stock valued at $30,000 after acquiring an additional 105 shares during the period. CWM Advisors LLC acquired a new stake in Hill-Rom during the 1st quarter valued at approximately $39,000. Lloyd Advisory Services LLC. acquired a new stake in Hill-Rom during the 4th quarter valued at approximately $41,000. Finally, Optimum Investment Advisors acquired a new stake in Hill-Rom during the 1st quarter valued at approximately $50,000. Institutional investors and hedge funds own 85.68% of the company’s stock.

Several research analysts recently commented on the stock. Morgan Stanley reduced their price target on shares of Hill-Rom from $138.00 to $125.00 and set an “overweight” rating on the stock in a research note on Friday, March 27th. Barclays reaffirmed a “buy” rating and issued a $125.00 price target on shares of Hill-Rom in a research note on Tuesday, April 14th. Finally, UBS Group reduced their price target on shares of Hill-Rom from $130.00 to $125.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $126.20.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

See Also: How is inflation measured?

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.